IRIS
RIGAMONTI, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.847
NA - Nord America 1.263
AS - Asia 470
SA - Sud America 21
AF - Africa 10
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.620
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.228
IE - Irlanda 742
IT - Italia 344
SE - Svezia 276
UA - Ucraina 164
DE - Germania 162
HK - Hong Kong 115
SG - Singapore 96
IN - India 81
CN - Cina 52
FI - Finlandia 47
FR - Francia 42
VN - Vietnam 39
CA - Canada 29
IR - Iran 23
CZ - Repubblica Ceca 20
TR - Turchia 19
GB - Regno Unito 16
KR - Corea 8
PE - Perù 8
PK - Pakistan 8
MY - Malesia 7
NL - Olanda 7
AU - Australia 6
JP - Giappone 6
KE - Kenya 6
BE - Belgio 5
BR - Brasile 4
CH - Svizzera 4
CO - Colombia 4
ES - Italia 4
MO - Macao, regione amministrativa speciale della Cina 4
MX - Messico 4
PH - Filippine 4
CL - Cile 3
EU - Europa 3
GR - Grecia 3
RO - Romania 3
TH - Thailandia 3
AR - Argentina 2
CU - Cuba 2
IL - Israele 2
LT - Lituania 2
LY - Libia 2
RS - Serbia 2
RU - Federazione Russa 2
TW - Taiwan 2
BD - Bangladesh 1
EG - Egitto 1
MK - Macedonia 1
NO - Norvegia 1
SN - Senegal 1
Totale 3.620
Salva come PNG Salva come JPEG
Città #
Dublin 730
Jacksonville 308
Hong Kong 104
Chandler 99
Lawrence 82
Princeton 82
Wilmington 71
San Mateo 69
Singapore 56
Dearborn 54
Piemonte 49
Dong Ket 36
Novara 33
Ashburn 27
Bremen 27
Ann Arbor 25
Turin 25
Andover 21
Beijing 20
Boardman 20
Milan 20
Brno 18
Helsinki 16
Norwalk 16
Chennai 14
Monmouth Junction 13
Toronto 11
Kocaeli 10
West Jordan 10
Ardabil 9
Augusta 8
Fairfield 8
Frankfurt am Main 8
Istanbul 8
Montreal 8
Rome 8
Mülheim 7
New York 7
Philadelphia 7
Royal Leamington Spa 7
Sham Shui Po 7
Woodbridge 7
Alessandria 6
Leawood 6
Nairobi 6
Nanjing 6
Brussels 5
Chimbote 5
Hefei 5
Naples 5
Palermo 5
Paris 5
Seattle 5
Strasbourg 5
Vancouver 5
Vedano Olona 5
Berlin 4
Brescia 4
Cassano Magnago 4
Grafing 4
Macao 4
Mumbai 4
Munich 4
Redwood City 4
Senigallia 4
Tehran 4
Zanjan 4
Athens 3
Bangkok 3
Bien Hoa 3
Busalla 3
Busanjin-gu 3
Gorgonzola 3
Goyang-si 3
Greenville 3
Houston 3
Ipoh 3
Lima 3
Padova 3
Pioltello 3
Rennes 3
San Diego 3
Sialkot 3
Sydney 3
Temuco 3
Vercelli 3
Amsterdam 2
Appiano Gentile 2
Arcene 2
Bagnoli del Trigno 2
Benghazi 2
Berbenno Di Valtellina 2
Bollate 2
Borgomanero 2
Brisbane 2
Bucharest 2
Bulandshahr 2
Caloocan City 2
Cambridge 2
Chicago 2
Totale 2.368
Salva come PNG Salva come JPEG
Nome #
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 213
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 140
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 98
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 89
Liver infection and COVID-19: the electron microscopy proof and revision of the literature 80
Gas6/TAM system: A key modulator of the interplay between inflammation and fibrosis 79
Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis 75
Association between red cell distribution width and response to methotrexate in rheumatoid arthritis 70
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 66
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 66
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 65
Chronic hepatitis C is mild in menstruating women 62
Liver stiffness, not fat liver content, predicts the length of QTc interval in patients with chronic liver disease 56
Pathophysiological Role and Therapeutic Implications of Vitamin D in Autoimmunity: Focus on Chronic Autoimmune Diseases 55
Evaluation of liver fibrosis in chronic hepatitis C with a computer-assisted morphometric method 54
Detection of auto-antibodies against cytochrome P4502E1 (CYP2E1) in chronic hepatitis C 52
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort 50
Rates of symptomatic SARS-CoV-2 infection in patients with autoimmune liver diseases in Northern Italy: a telemedicine study 50
Antiphospholipid antibodies associated with alcoholic liver disease specifically recognise oxidised phospholipids 49
CYP2E1 autoantibodies in liver diseases 49
Chronic hepatitis C treated with phlebotomy alone: biochemical and histological outcome 48
Heterozygous β-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C 48
Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders 48
Reduced activity of B lymphocytes, recognised by Sysmex XN-2000™ haematology analyser, predicts mortality in patients with coronavirus disease 2019 48
Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis 48
Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of necroinflammation of recurrent hepatitis C 47
Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C 45
Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms 45
Giant liver fibrous tumours metastatic from atypical recurrent meningeal neoplasia 44
Outcome of COVID-19 in Patients with Autoimmune Hepatitis: an International Multi-Centre Study 44
Impact of the COVID-19 outbreak on an Italian cohort of systemic sclerosis patients 42
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 41
Coronavirus Disease 2019 (COVID‐19) in autoimmune hepatitis: a lesson from immunosuppressed patients 41
Anti-phospholipid antibodies associated with alcoholic liver disease target oxidized phosphatidylserine on apoptotic cell plasma membranes 40
Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C 40
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 40
Elastography in Liver-Transplanted Patients 39
Iron, hepatic stellate cells and fibrosis in chronic hepatitis C 38
HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment 38
High reproducibility of spleen stiffness measurement by vibration-controlled transient elastography with a spleen-dedicated module 37
Gender and liver fibrosis in chronic hepatitis: the role of iron status 37
Severe thombocytopenia and clinical bleeding associated with rituximab infusion in a lynphoma patient with massive splenomegaly without leukemic invasion 36
Authors’ response re: “The non-invasive diagnosis of cirrhosis using the Fibroscan must be performed with cause-specific stiffness cut-offs” 36
Exposure to Plasma From Non-alcoholic Fatty Liver Disease Patients Affects Hepatocyte Viability, Generates Mitochondrial Dysfunction, and Modulates Pathways Involved in Fat Accumulation and Inflammation 35
Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease 35
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 35
Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: Results from a 29-year cohort study 34
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon 33
Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis 31
High prevalence of acute onset autoimmune hepatitis in males: A real-life cohort from Northern Italy 30
Adequate vs. deep response to UDCA in PBC: To what extent and under what conditions is normal ALP level associated with complication-free survival gain? 28
Hepatocellular carcinoma after direct-acting antiviral agents: Can liver stiffness kinetics help identify patients at lower risk? 28
LIVER BIOPSY TECHNIQUES: AUTOMATED ASPIRATION NEEDLES PROVIDE ADEQUATE TISSUE SAMPLES 27
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 27
Spleen Stiffness Measured by Transient Elastography Accurately Predicts Esophageal Varices in Liver Cirrhosis 27
Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis C 27
Predicting the advent of ascites and other complications in primary biliary cirrhosis: a staged model approach 26
Can protocol liver biopsy be avoided to evaluate post-transplant hepatitis C recurrence? Transient elastography makes it possible 26
Diagnosis of cirrhosis by transient elastography: what is hidden behind misleading results 26
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 26
Long term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years 26
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes 26
ERCP and short-term stent-trial in patients with anastomotic biliary stricture following liver transplantation 26
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 26
Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges 26
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 26
Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease 25
Transjugular liver biopsy: The Tru-cut needle might be better for stiffer livers 25
Transient elastography in the early prediction of progressive recurrent hepatitis C following liver transplantation 24
Do not trivialize the Fibroscan® examination, value its accuracy 24
Transient elastography identifies liver recipients with nonviral graft disease after transplantation: A guide for liver biopsy 24
Severe thrombocytopenia and clinical bleeding associated with rituximab infusion in a lymphoma patient with massive splenomegaly without leukemic invasion 24
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients 24
SURVIVAL FOLLOWING THE DEVELOPMENT OF ASCITES AND/OR PERIPHERAL OEDEMA IN PRIMARY BILIARY CIRRHOSIS: A STAGED PROGNOSTIC MODEL 24
Dual cut-off transient elastography to assess liver fibrosis in chronic hepatitis B: a cohort study with internal validation 24
Transient elastography in the assessment of liver fibrosis in adult thalassemia patients 24
Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury 24
Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study 23
Transient elastography 23
Ursodeoxycholic acid improves bilirubin but not albumin in primary biliary cirrhosis: further evidence for nonefficacy 23
Liver stiffness, a non-invasive marker of liver disease: a core study group report 23
Might rapid virological response be used as a stopping rule in liver transplant recipients treated with pegylated interferon plus ribavirin? 22
Post-liver transplantation graft biopsies should not be used to assess the IL28B donor genotype in HCV recipients 22
Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation 22
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 22
Feasibility and reproducibility of spleen transient elastography and its role in combination with liver transient elastography for predicting the severity of chronic viral hepatitis 20
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort 19
Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation 19
Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C 18
Emerging Issues in the Immunopathogenesis, Diagnosis and Clinical Management of Primary Biliary Cirrhosis Associated with Systemic Sclerosis 17
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 15
Excellent outcome in patients with primary biliary cholangitis in Northwest Italy followed up for up to 30 years 14
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma 14
Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis 13
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis 12
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis 11
Development and validation of a scoring system to predict response to obeticholic acid in primary biliary cholangitis 4
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 3
The evolving landscape of autoimmune hepatitis: an ambispective cohort study 3
Position paper of the Italian Association for the Study of the Liver (AISF): Management and treatment of primary biliary cholangitis 2
Totale 3.775
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.557
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.557
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020330 1 1 18 0 37 37 49 14 31 64 26 52
2020/2021562 65 0 73 0 88 21 71 11 79 31 81 42
2021/2022613 17 47 79 44 38 17 43 20 60 37 82 129
2022/20231.418 155 84 70 19 69 87 56 60 718 19 48 33
2023/2024767 38 61 43 23 107 38 142 60 28 42 54 131
2024/202527 27 0 0 0 0 0 0 0 0 0 0 0
Totale 3.777